• Sopharma reported preliminary September 2026 sales growth of 13% year over year in its October 20, 2026 update.
• Domestic sales rose 20% in September; export sales increased 8%.
• Sales for January–September 2026 grew 39% year over year.
• Nine-month export sales jumped 62%; domestic sales rose 5%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sopharma AD published the original content used to generate this news brief on October 20, 2026, and is solely responsible for the information contained therein.